Chagas Disease Treatment Market - Industry
Insights, Trends, Opportunity And Analysis 2025
Chagas disease is an endemic in 21 Latin American countries caused by kinetoplastid protozoan
parasite, Trypanosoma cruzi, primarily transmitted by large, blood-sucking reduviid insects
widely known as 'the kissing bugs'. Moreover, the disease can be transferred through other
means such as blood transfusion, organ transplantation, as well as congenital and oral
transmissions. The recent past has witnessed spread of Chagas disease to developed economies
such as Europe and North America, due to migration of people from Latin America to others
countries. For instance, according a study published in National Center for Biotechnology
Information (NCBI), in 2015, 4.2% of Latin American living in European countries were
chronically affected with Chagas disease. Benznidazole is the only FDA approved treatment
indicated for the treatment of Chagas disease. However, the drug, Nifurtimox manufactured by
Bayer AG, is in the World Health Organization's (WHO) list of 'Essential Medicines' and used in
the treatment of Chagas disease.
Download PDF Brochure Of This Research Report @
https://www.coherentmarketinsights.com/insight/request-pdf/934
Increasing approval to Chagas disease treatment drugs is expected to drive growth of the global
Chagas disease treatment market
Benznidazole is an essential antiparasitic drug used for the treatment of Chagas disease. In April
2018, Argentinian National Administration for Drugs, Food, and Medical Technologies (ANMAT)
approved Laboratorio Elea Phoenix SA’s drug benznidazole for pediatric indication used for the
treatment of Chagas disease. Currently, Argentina has the highest number of people suffering
from Chagas disease. For instance, according to data published by Mundo Sano
(Nongovernmental foundation in Argentina), in 2017, around 7,300,000 people were exposed to
Chagas disease and about 1,600,000 were infected, in Argentina. Hence, approval of novel
drugs is expected to fuel the market growth in the near future. Such approval of Chagas disease
treatment drugs is expected to boost growth of Chagas disease treatment market in the near
future.